(Q36911419)

17 August 2017

1 reference

title

Management of inherited von Willebrand disease in 2007. (English)

1 reference

17 August 2017

Pier Mannuccio Mannucci

series ordinal

2

object named as

Pier Mannuccio Mannucci

1 reference

17 August 2017

Augusto B Federici

1

1 reference

PubMed ID

17701477

17 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

17 August 2017

1 reference

17 August 2017

39

1 reference

17 August 2017

5

1 reference

17 August 2017

346-358

1 reference

Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant agains

17 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

The 80th anniversary of von Willebrand's disease: history, management and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Guidelines for the diagnosis and management of von Willebrand disease in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Clinical diagnosis of von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Gene deletions correlate with the development of alloantibodies in von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Treatment of von Willebrand's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Hyponatremia and seizures in young children given DDAVP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Thrombosis following desmopressin for uremic bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

Long-term prophylaxis in von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890701513738

10.1080/07853890701513738

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17701477